Stocktoria
Novartis AG NOVN.SW
CH · SIX Swiss Exchange · XSWX · stock · Healthcare · website
Novartis AG statistics & valuation
Market cap$241.5B
P / E17.3×
P / S4.3×
P / B5.2×
P / FCF15.8×
Dividend yield3.24%
Net margin24.7%
Return on equity30.3%
FCF margin26.9%
Multiples are price-derived and refreshed daily; everything else is from filings.
P / E vs its own history
Novartis AG trades at about 17.7× earnings — near its 10-year norm (10-year range 12.6×–24.7×, median 16.3×).
12.6×
24.7×
Shaded band = 10-year range (12.6×–24.7×); dot = today's 17.7×.
Historical P/E = month-end price near each fiscal year-end ÷ that year's EPS. A read on whether the stock is cheap or dear relative to how it has typically been valued — not a forecast.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Gross margin | 75.8% | 75.2% | 73.3% | 73.4% |
| Operating margin | 31.1% | 28.1% | 20.9% | 18.3% |
| Net margin | 24.7% | 23.1% | 31.8% | 16.0% |
| FCF margin | 26.9% | 26.7% | 25.1% | 27.6% |
| Return on assets | 12.6% | 11.7% | 14.9% | 5.9% |
| Return on equity | 30.3% | 27.1% | 31.8% | 11.7% |
| Debt / equity | 0.61× | 0.49× | 0.40× | 0.34× |
| Current ratio | 1.12 | 1.04 | 1.16 | 1.29 |
Source: company filings via Yahoo Finance · CH · as of 2025-12-31. Figures in CHF; non-US fundamentals are aggregated by Yahoo (shorter history); facts plus Stocktoria's own computed scores — not investment advice.